
December 2022
Investor Insights
The Secret to Ageless Beauty
This luxe skincare brand is blending biology and technology to create ever-youthful skin.
Who doesn’t want to achieve timeless beauty? But with time and the world we live in, our skin becomes dull and lifeless until we take care of it properly with diet and products. Diet can help restore lost texture, but it is ineffective without a proper skincare regimen.
Enter biotech beauty. Many brands claim to have the secret to ageless skin, but in truth, those are just concoctions of harmful chemicals that damage the skin in the long run. However, ethical brands such as this depend on biotechnology to create bio-identical ingredients like Epidermal Growth Factor that cannot be ethically or safely sourced elsewhere. The brand is using biotechnology to formulate and create anti-aging products with the highest effectiveness that are being used and referred to by thousands of existing customers worldwide.
Source: Refirmation Products/neodermisfactor.com
Epidermal Growth Factor
Touted as a healer, stimulant, and growth factor, EGF is a peptide found in humans and mice. It cannot be found in nature and can only be produced in the body or in labs. Awarded the Nobel Prize for its discovery, EGF is taking the skincare industry by storm. Growth factors function as regulatory proteins that mediate signaling pathways. EGF, approved for use in cosmetics around the world, improves the appearance and health of the skin. It improves skin hydration and firmness while reducing fine lines and wrinkles, dullness, aging, and hyperpigmentation.
Source: Refirmation Products/neodermisfactor.com
The sustainable beauty industry is growing by leaps and bounds, thanks to ethical consumers. A large part of it can be attributed to biotech companies that create ingredients that are allergen-free, paraben-free, and dermatologist-tested. The benefits of these on the skin are immense. The brand is making tremendous strides in this quest for sustainable skincare that combines the best of nature and science.
Other ingredients available in its skincare products besides EGF include peptides, which can stimulate new collagen for improved wrinkled skin; hydroxy acids, which decrease hyperkeratinized skin and stimulate elastic fibers; and hyaluronic acid, a sugar molecule that binds water with collagen to improve skin hydration.

Source: Refirmation Products/neodermisfactor.com
The recently launched brand is also the recipient of many international press accolades and awards that include those from Ocean Drive Magazine, Miami Living Magazine, and Bustle’s “2022 Most Wanted Summer Awards”.
Biotech Is The Future Of Beauty
Biotechnology is an excellent trend that will make products more inclusive rather than exclusive for users.
Organic, natural, and ethical ingredients allow for the best outcomes for your skin. The brand has all the ingredients to make you and the planet happy. Combining biology and technology, the brand is bringing the best of both worlds to you with award-winning ingredients such as EGF. And the outcomes speak for themselves.
Biotechnological beauty is not a passing fad, but rather the way forward. However, it is also an untapped market at present. According to the Business Wire Report, the global biotech ingredients market reached a value of $53.8 billion in 2021, and looking forward, it is expected to reach $72.6 billion by 2027 (link).
Source: Refirmation Serum/neodermisfactor.com
Considering this, in the coming years, the demand for such products will only rise. In order to make it more accessible to consumers, the acclaimed brand is now looking for investors to boost its production and availability. If you are interested in learning more or investing in this skincare brand, please contact us.

and reforestation to deliver results that are in line with the UN Sustainable Development Goals. It specializes in giving clients advice on energy efficiency, clean energy options, tr
carbon market participants into a global ecosystem for financial and environmental gains, with a focus on energy, water, and food. It serves as a distributed hub and connective tissue to link multiple international carbon exchanges and other buyside carbon emitters and custodians with supply-side carbon offset projects and ESG project owners globally to drive distribution. For the purpose of keeping carbon credit ledger data up to date, their software also communicates with reputable third-party registries.
The firm’s platform matches investors with advanced learners by exploiting the fully scalable and high-return potential of non-loan Income Share Agreements (ISA’s). Investors in ISA’s may finely tune their investment criteria to match their corporate objectives, which may include CSR targets. Currently, the firm is proposing two types of investment opportunity: in the infinite possibilities of direct investments in ISA’s and, more conventionally, investments in shares (and, as the firm is designated by the French state as an innovative firm, offers the possibility of French residency/citizenship).
After a year of service, the e-ferry’s operators concluded that the system has a highly sustainable energy efficiency of 85%, almost twice that of diesel boats. With this background, the US$20 billion market expectation for electric watercraft seems more than reasonable. To support this industry, we are following a firm that has designed, and begun delivering, an electric-powered watercraft. Destined for the lucrative leisure market, this is a mere stepping stone to the huge water taxi market for which a design is already complete.
technology that detects one of the deadliest types of cancer and treats it without damaging healthy cells and tissues. Its electromagnetic stimulation, combined with a nanotechnology system, has demonstrated the preclinical treatment to be safe and effective. The medical device has been classified as class III to chronically treat and reduce cancer’s mass significantly from further development. The firm has started Phase I and seeking investments to support this phase. Based on Phase I results, which will be within 12-15 months, they plan an IPO for Phase II, the last one before the commercial launch in North America by 2024.





































